New Key Statistics Module, Z-Score and F-Score
NAS:OCX Key Ratios
| Market Cap $ M | 38.36 |
| Enterprise Value $ M | 30.59 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.16 |
| Price/Sales | 14.50 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -3.55 |
| Beneish M-Score | -3.15 |
| 10-y EBITDA Growth Rate % | 10.60 |
| 5-y EBITDA Growth Rate % | 21.20 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.43 |
| EV-to-EBITDA | -2.80 |
| PEG | -- |
| Shares Outstanding M | 13.36 |
| Net Margin (%) | -1,848.37 |
| Operating Margin % | -1,491.48 |
| Pre-tax Margin (%) | -1,653.69 |
| Quick Ratio | 1.49 |
| Current Ratio | 1.49 |
| ROA % (ttm) | -32.54 |
| ROE % (ttm) | -79.90 |
| ROIC % (ttm) | -30.83 |
| Dividend Yield % | -- |
| Altman Z-Score | -6.02 |
OCX Number of Guru Trades
OCX Volume of Guru Trades
Gurus Latest Trades with NAS:OCX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:OCX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OncoCyte Corp Insider Transactions
No Available Data
News about NAS:OCX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers